Posts by Vineeth

At Rosetrees, we are committed to supporting innovative research and the next generation of clinical academics. Through our partnership with the Francis Crick Institute, the Crick–Rosetrees Fellowship provides a vital opportunity for early-career clinician scientists to develop independent research alongside their clinical work. One of our current fellows, Dr Shahana Sengupta, exemplifies the ambition and…

Rosetrees has been a long-time supporter of the pioneering research led by Professor Paolo De Coppi and his team at UCL GOSH ICH, including funding some of the early work over a decade ago. This support has contributed to a major breakthrough in regenerative medicine, offering new hope for children born with life-threatening oesophageal conditions.…

Rosetrees is delighted to congratulate Professor Charles Swanton on being awarded the 2026 Sjöberg Prize, one of the world’s most prestigious awards in cancer research. Professor Swanton, based at the Francis Crick Institute, has transformed our understanding of how tumours evolve. His research has revealed that cancers are not uniform masses of identical cells, but…

Rosetrees is proud to partner with The National Brain Appeal through their Innovation Fund, which seed-funds cutting-edge projects to improve diagnosis, treatment, and care for people with neurological conditions. One project we support is led by Dr Tim Tierney (UCL), Senior Research Fellow, developing a low-cost brain imaging system to make epilepsy surgery more accessible…

In 2022, Rosetrees Trust awarded a Seedcorn grant to Dr Thomas Marjot, supporting early-stage research into how metabolic processes contribute to liver disease. That early investment has now helped lead to an important new discovery: researchers at the University of Oxford have shown that the world’s most common liver disease follows a strong day–night rhythm,…

A world-first clinical trial is set to begin testing LungVax, an experimental vaccine designed to prevent lung cancer in people at high risk. Developed by researchers at the University of Oxford and UCL, LungVax could mark a major step forward in tackling the UK’s deadliest cancer, responsible for 20% of all cancer deaths. Lung cancer is notoriously hard to detect early,…

We’re delighted to share that Rosetrees funded Professor Charles Swanton, has been awarded the European Association for Cancer Research’s 2026 Mike Price Gold Medal Award — a prestigious honour recognising senior scientists who have made exceptional contributions to cancer research across Europe. This follows another major achievement: last month, Charlie was elected to the U.S.…

Dr. Sophie Adler and Dr. Konrad Wagstyl, leading epilepsy researchers at King’s College London, have jointly received the 2025 Michael Prize in the “Imaging” category for their ground-breaking work on a Rosetrees-funded project. Awarded biennially, the Michael Prize is one of the most prestigious international honours in epileptology, recognising outstanding scientific contributions to the field.…

A team at the Liverpool School of Tropical Medicine has uncovered another use for a repurposed drug that could be used in the fight against mosquito-borne diseases. The Rosetrees-funded research led by Dr Lee Haines and talented PhD student Mr Zachary Stavrou-Dowd was recently published in Parasites & Vectors. The team investigated a range of…

Rosetrees is proud to congratulate the team at the Cambridge Children’s Hospital (CCH) Innovation Hub on winning the “Further, Faster Together” award at the Cancer Research Horizons Innovation and Entrepreneurship Awards. This prestigious national prize celebrates outstanding collaborations between academia and industry that are accelerating progress in cancer research and care. The CCH Innovation Hub,…